| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/08/2004 | US20040068764 Method of enhancing virus-resistance in plants and producing virus-immune plants |
| 04/08/2004 | US20040068380 Human gtp-rho binding protein 2 |
| 04/08/2004 | US20040068095 Comprises polypeptide for diagnosis, prevention and treatment of cell proliferative, inflammatory, nervous system and autoimmune diseases |
| 04/08/2004 | US20040068003 Compounds useful for the inhibition of ALDH |
| 04/08/2004 | US20040067917 Processes for preparation of 9, 11-epoxy steroids and intermediates useful therein |
| 04/08/2004 | US20040067885 Use of inhibitors for the treatment of RTK-hyperfunction-induced disorders, particularly cancer |
| 04/08/2004 | US20040067871 Detection of polymorphism alleles in labeled chromosome |
| 04/08/2004 | US20040067588 Monitoring and evaluating DNA maintainance mechanisms of plant nuclear and plastids genomes; gene therapy and disease resistance in plants |
| 04/08/2004 | US20040067586 Comprises viral nucleotide sequences coding protein for treatment of tumors; gene therapy |
| 04/08/2004 | US20040067559 Using strand displacement replication to detect, quantify and characterize preferential nucleotide sequences; high throughput assay |
| 04/08/2004 | US20040067555 Recombinant hosts suitable for simultaneous saccharification and fermentation |
| 04/08/2004 | US20040067548 Preparing assay sample by staining specimen using fluorescent dye, thereby producing difference in fluorescent intensity between live and dead bacteria, detecting optical information from sample, classifying and counting live and dead bacteria |
| 04/08/2004 | US20040067547 Taking sample of fluid containing any micro-organisms present, optionally culturing sample, measuring zeta potentials of any micro-organisms present, comparing measured zeta potentials with table of zeta potentials of known microorganisms |
| 04/08/2004 | US20040067545 Reagent for assaying lipid |
| 04/08/2004 | US20040067543 Delivering protein or gene and a pharmacological agent to a mammal wherein two different states of the process or condition (cancer) is generated via expression; bioassay, microassay or bioinformatics data assay |
| 04/08/2004 | US20040067542 Determining the aetiology of carcinogenesis in a mammal; comparing with normal cell/tissue; detection by immunohistochemistry or blotting techniques; use in diagnosis of prostate, breast and skin cancer |
| 04/08/2004 | US20040067540 Rapid method for screening compounds for in vivo activity |
| 04/08/2004 | US20040067539 Contacting mixture of ligand/anti-ligand and allowing binding to take place; isolating and amplifying; use in analyzing differential protein expression in cells |
| 04/08/2004 | US20040067538 Prevention and treatment of amyloid-associated disorders |
| 04/08/2004 | US20040067533 Method to reduce false positive outcomes in prion tests |
| 04/08/2004 | US20040067524 Chlamydia protein, gene sequence and uses thereof |
| 04/08/2004 | US20040067521 Sequence specific recognition reagents (oligonucleotide, monoclonal antibodies) attached to a solid substrate; sequencing, fingerprinting and mapping biological polymers |
| 04/08/2004 | US20040067519 Kit for amplifying and/or determining the molecular structure; labelled oligonucleotides; genotyping; patients with alleles encoding alanine at position 9 of the signal peptide has an increased risk; colorectal |
| 04/08/2004 | US20040067515 Human proteinase molecules |
| 04/08/2004 | US20040067512 Nucleic acids corresponding to the Alpha-2-Macroglobulin gene which are risk factors for Alzheimer's Disease , which contain one or more of the Single Nucleotide Polymorphisms; diagnostic methods, methods of data analysis, and drug discovery |
| 04/08/2004 | US20040067511 Circular probe amplification (cpa) using energy-transfer primers |
| 04/08/2004 | US20040067510 Model of transmissible spongiform encephalopathic (tse) disease |
| 04/08/2004 | US20040067508 Method for the simultaneous amplification of multiple sequences in a pcr reaction and marking thereof |
| 04/08/2004 | US20040067507 A method of predicting the liver toxicity In Vivo or In Vitro comprising obtaining a biological sample from an individual, cell culture or explant treated with the agent, measurinf the expression of predictive genes in the sample |
| 04/08/2004 | US20040067503 Functionalized nanoparticles and methods of use |
| 04/08/2004 | US20040067502 A method for detecting the binding between binding sites of molecules and nanoparticles; used in diagnosis, drug discovery or therapy |
| 04/08/2004 | US20040067501 Method of selection by two-dimensional separation, of nucleic acids that bind to a target with high affinity |
| 04/08/2004 | US20040067500 Compositions and methods relating to the peroxisomal proliferator activated receptor-alpha mediated pathway |
| 04/08/2004 | US20040067498 Detection of nucleic acid sequences by cleavage and separation of tag-containing structures |
| 04/08/2004 | US20040067495 Polynucleic acid and polyamino acid binding substrate |
| 04/08/2004 | US20040067494 Least-square deconvolution (LSD): a method to resolve DNA mixtures |
| 04/08/2004 | US20040067493 Complexity management of genomic DNA |
| 04/08/2004 | US20040067492 Reverse transcription on microarrays |
| 04/08/2004 | US20040067491 Diagnosis of diseases associated with metabolism |
| 04/08/2004 | US20040067490 Nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, their derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide |
| 04/08/2004 | US20040067489 Method to determine the risk for side effects of an SSRI treatment in a person |
| 04/08/2004 | US20040067487 Means and methods for monitoring antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS |
| 04/08/2004 | US20040067486 Nucleic acid containing one or more adaptive mutations, and Hepatitis c Virus (HCV) replicon enhanced cells ( cells having an increased ability to maintain an HCV replicon) |
| 04/08/2004 | US20040067242 Multi-subtype FIV vaccines |
| 04/08/2004 | US20040067237 Using a rational selection of representative PspAs from various families of clades to produce broadly efficacious Pneumococcal vaccines |
| 04/08/2004 | US20040067226 Elongation of fatty acids(ELF) polypeptides and carrier mixtures administered for prophylaxis or prevention of vision defects |
| 04/08/2004 | US20040067218 Extramedullary adipose tissue cells and use thereof for regenerating hematopoietic and muscular tissue |
| 04/08/2004 | US20040067166 Strip biosensor; termination of fluid flow at interface; multilayer, substrate, spacer and covering |
| 04/08/2004 | DE10245644A1 Verfahren zum Nachweis von Analyten A method for detecting analytes |
| 04/08/2004 | DE10245145A1 Verfahren zum Nachweis von SNPs auf polydimensionalen Microarrays A method for the detection of SNPs on microarrays polydimensional |
| 04/08/2004 | DE10239585A1 New nucleic acid molecules, useful for detecting plant material, e.g. genetically modified material in food, are designed to amplify the chloroplast tRNA-Leu gene |
| 04/08/2004 | DE10232776A1 New oligonucleotides for specific detection of microorganisms, useful e.g. for detecting or quantifying microbes on the skin, in foods, clinical samples or water, by in situ hybridization |
| 04/08/2004 | CA2523618A1 Methods for promoting dopaminergic neuronal development by using ng4a-subfamily and wnt-ligands |
| 04/08/2004 | CA2500979A1 Methods to predict cholesterol elevations during immunosuppressant therapy |
| 04/08/2004 | CA2500551A1 Subtelomeric dna probes and method of producing the same |
| 04/08/2004 | CA2500384A1 Antibody tools for the diagnostic use in the medical therapy with inhibitors of histone deacetylases |
| 04/08/2004 | CA2500285A1 Compositions and methods for the use of fmoc derivatives in dna/rna synthesis |
| 04/08/2004 | CA2500272A1 A method to diagnose schizophrenia using blood |
| 04/08/2004 | CA2500270A1 Nucleic acid constructs for gene expression |
| 04/08/2004 | CA2500188A1 Method for assaying replication of hbv and testing susceptibility to drugs |
| 04/08/2004 | CA2500140A1 Crystal structure of chorismate synthase and uses thereof |
| 04/08/2004 | CA2500040A1 Cell-based fluorescence resonance energy transfer (fret) assays for clostridial toxins |
| 04/08/2004 | CA2499880A1 Methods and compositions for modification of splicing of pre-mrna |
| 04/08/2004 | CA2499852A1 Methods for prediction and prognosis of cancer, and monitoring cancer therapy |
| 04/08/2004 | CA2499843A1 Novel compositions and methods for the treatment of psoriasis |
| 04/08/2004 | CA2499320A1 Susceptibility gene for human stroke; methods of treatment |
| 04/08/2004 | CA2499042A1 Functional mutations in respiratory syncytial virus |
| 04/08/2004 | CA2498483A1 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome |
| 04/08/2004 | CA2494899A1 Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer |
| 04/08/2004 | CA2485970A1 Methods for diagnosing htlv-i-mediated diseases |
| 04/07/2004 | EP1405923A2 Gene mapping method using microsatellite genetic polymorphism markers |
| 04/07/2004 | EP1405922A2 Substrates for beta-lactamase and uses thereof |
| 04/07/2004 | EP1405921A1 Detection of susceptibility to autoimmune diseases, especially type 1 diabetes |
| 04/07/2004 | EP1405920A2 Improved FRET process |
| 04/07/2004 | EP1405918A1 Bacteria counting method, bacteria counting apparatus, and reagent kit for counting bacteria |
| 04/07/2004 | EP1405911A1 Interaction trap systems for detecting protein interactions |
| 04/07/2004 | EP1405909A1 Method of uniformizing dna fragment contents and subtraction method |
| 04/07/2004 | EP1405907A2 Conjugate of a tissue non-specific alkaline phosphatase and dextran, process for its production and use thereof |
| 04/07/2004 | EP1405666A2 Substrate for methods to determine analytes and methods to manufacture such substrates |
| 04/07/2004 | EP1405248A1 A method for gene mapping from chromosome and phenotype data |
| 04/07/2004 | EP1405083A2 Natural ligand of gpcr chemr23 and uses thereof |
| 04/07/2004 | EP1405082A2 Method for identifying compounds for the therapy of aging of the cardiovascular system |
| 04/07/2004 | EP1405081A2 Methods and compositions for modulating adenosine triphosphate (atp) in cells and preventing cell injury or death via post-translational modifications to atp synthase |
| 04/07/2004 | EP1405074A2 P5CRS AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 04/07/2004 | EP1405073A2 Cell enumeration |
| 04/07/2004 | EP1405070A2 Selection of target sites for antisense attack of rna |
| 04/07/2004 | EP1404880A2 Method for identifying nucleic acid molecules amplified in a polymerase chain reaction |
| 04/07/2004 | EP1404879A2 Method for detecting cytosine methylation by comparatively analysing single strands of amplificates |
| 04/07/2004 | EP1404878A1 Internal calibration standards for electrophoretic analyses |
| 04/07/2004 | EP1404877A2 New assays for preimplantation factor and preimplantation factor peptides |
| 04/07/2004 | EP1404876A2 Interferon alpha-14 polymorphism |
| 04/07/2004 | EP1404874A2 Screening method |
| 04/07/2004 | EP1404873A2 Chimeric immunomodulatory compounds and methods of using the same |
| 04/07/2004 | EP1404872A2 Method of selecting a dna sequence with transcription modulating activity using a vector comprising an element with a gene transcription repressing activity |
| 04/07/2004 | EP1404871A2 Method for treatment of cancer associated with elevated her 2 levels |
| 04/07/2004 | EP1404870A2 Function and application of tob gene in central nervous system of mammal |
| 04/07/2004 | EP1404869A2 Detection of microorganisms using inducible genes |
| 04/07/2004 | EP1404868A2 Compositions and methods relating to osteoarthritis |
| 04/07/2004 | EP1404867A2 Oligonucleotide transfection screening method |
| 04/07/2004 | EP1404866A1 Bioassay for myostatin |